CPRiL

4 Functional Relationships(s) Download
	Sentence	Compound Name	Protein Name	Organism
1	The first finding is that the oral bioavailability of cyclosporine A (CsA), which is an immunosuppressant, was decreased by increased first-pass metabolism due to elevated CYP3A and P-glycoprotein (P-gp) specifically in the upper small intestine after liver I/R.	Cyclosporine	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus
2	The first finding is that the oral bioavailability of cyclosporine A (CsA), which is an immunosuppressant, was decreased by increased first-pass metabolism due to elevated CYP3A and P-glycoprotein (P-gp) specifically in the upper small intestine after liver I/R.	Cyclosporine	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus
3	The first finding is that the oral bioavailability of cyclosporine A (CsA), which is an immunosuppressant, was decreased by increased first-pass metabolism due to elevated CYP3A and P-glycoprotein (P-gp) specifically in the upper small intestine after liver I/R.	Cyclosporine	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus
4	The first finding is that the oral bioavailability of cyclosporine A (CsA), which is an immunosuppressant, was decreased by increased first-pass metabolism due to elevated CYP3A and P-glycoprotein (P-gp) specifically in the upper small intestine after liver I/R.	Cyclosporine	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus